BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11724295)

  • 21. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
    Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIMS ion microscopy in cancer research: single cell isotopic imaging for chemical composition, cytotoxicity and cell cycle recognition.
    Chandra S; Lorey DR
    Cell Mol Biol (Noisy-le-grand); 2001 May; 47(3):503-18. PubMed ID: 11441958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: in vitro studies on human glioblastoma T98G cells.
    Chandra S; Lorey II DR; Smith DR
    Radiat Res; 2002 Jun; 157(6):700-10. PubMed ID: 12005550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer.
    Agarwal HK; Khalil A; Ishita K; Yang W; Nakkula RJ; Wu LC; Ali T; Tiwari R; Byun Y; Barth RF; Tjarks W
    Eur J Med Chem; 2015 Jul; 100():197-209. PubMed ID: 26087030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer.
    Tjarks W; Wang J; Chandra S; Ji W; Zhuo J; Lunato AJ; Boyer C; Li Q; Usova EV; Eriksson S; Morrison GH; Cosquer GY
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):695-8. PubMed ID: 11563094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).
    Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B
    Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular pharmacology of the D- and L-enantiomers of beta-5-o-carboranyl-2'-deoxyuridine.
    Hurwitz SJ; Ma L; Eleuteri A; Wright J; Moravek J; Schinazi RF
    Nucleosides Nucleotides Nucleic Acids; 2000 Mar; 19(3):691-702. PubMed ID: 10843501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
    Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
    Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
    Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
    Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
    Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA
    Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcellular imaging of RNA distribution and DNA replication in single mammalian cells with SIMS: the localization of heat shock induced RNA in relation to the distribution of intranuclear bound calcium.
    Chandra S
    J Microsc; 2008 Oct; 232(1):27-35. PubMed ID: 19017198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appraisal of SIMS applicability to boron studies in plants.
    Dérue C; Gibouin D; Verdus MC; Lefebvre F; Demarty M; Ripoll C; Thellier M
    Microsc Res Tech; 2002 Jul; 58(2):104-10. PubMed ID: 12203710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.
    Yang W; Barth RF; Wu G; Kawabata S; Sferra TJ; Bandyopadhyaya AK; Tjarks W; Ferketich AK; Moeschberger ML; Binns PJ; Riley KJ; Coderre JA; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
    Clin Cancer Res; 2006 Jun; 12(12):3792-802. PubMed ID: 16778107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
    Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early effects of boron neutron capture therapy on rat glioma models.
    Nakagawa N; Akai F; Fukawa N; Fujita Y; Suzuki M; Ono K; Taneda M
    Brain Tumor Pathol; 2007; 24(1):7-13. PubMed ID: 18095138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of lipophilicity on binding of boronated DNA-intercalating compounds in human glioma spheroids.
    Gedda L; Ghaneolhosseini H; Nilsson P; Nyholm K; Pettersson J; Sjöberg S; Carlsson J
    Anticancer Drug Des; 2000 Aug; 15(4):277-86. PubMed ID: 11200503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading.
    Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; Muolo M; D'Amore E; Maraviglia B; Lazzarino G; Pastore FS
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S34-6. PubMed ID: 19375337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.